Trimetazidine, Administered at the Onset of Reperfusion, Ameliorates Myocardial Dysfunction and Injury by Activation of p38 Mitogen-Activated Protein Kinase and Akt Signaling

This publication has 40 references indexed in Scilit:

• Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart
  Journal of Molecular and Cellular Cardiology, 2009
• Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression
  The Journal of Pharmacology and Experimental Therapeutics, 2009
• Sulfaphenazole Protects Heart Against Ischemia–Reperfusion Injury and Cardiac Dysfunction by Overexpression of iNOS, Leading to Enhancement of Nitric Oxide Bioavailability and Tissue Oxygenation
  Antioxidants & Redox Signaling, 2009
• Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction
  American Journal of Physiology-Heart and Circulatory Physiology, 2009
• Cardioprotection by Sulfaphenazole, a Cytochrome P450 Inhibitor: Mitigation of Ischemia-Reperfusion Injury by Scavenging of Reactive Oxygen Species
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Antiapoptotic mechanisms of benidipine in the ischemic/reperfused heart
  British Journal of Pharmacology, 2004
• Protein kinase activation and myocardial ischemia/reperfusion injury
  Cardiovascular Research, 2004
• Trimetazidine
  Drugs, 1999
• Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
  Journal of Clinical Investigation, 1994
• Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone.
  Journal of Clinical Investigation, 1988